An Explainable Machine Learning Framework for the Accurate Diagnosis of Ovarian Cancer
Preprint
Abstract
Ovarian cancer (OC) is one of the most prevalent types of cancer in women. Early and accurate diagnosis is crucial for the survival of the patients. However, the majority of women are diagnosed in advanced stages due to the lack of effective biomarkers and accurate screening tools. While previous studies sought a common biomarker, our study suggests different biomarkers for the premenopausal and postmenopausal populations. This can provide a new perspective in the search for novel predictors for the effective diagnosis of OC. Lack of explainability is one major limitation of current AI systems. The stochastic nature of the ML algorithms raises concerns about the reliability of the system as it is difficult to interpret the reasons behind the decisions. To increase the trustworthiness and accountability of the diagnostic system as well as to provide transparency and explanations behind the predictions, explainable AI has been incorporated into the ML framework. SHAP is employed to quantify the contributions of the selected biomarkers and determine the most discriminative features. A hybrid decision support system has been established that can eliminate the bottlenecks caused by the black-box nature of the ML algorithms providing a safe and trustworthy AI tool. The diagnostic accuracy obtained from the proposed system outperforms the existing methods as well as the state-of-the-art ROMA algorithm by a substantial margin which signifies its potential to be an effective tool in the differential diagnosis of OC.Keywords
All Related Versions
This publication has 47 references indexed in Scilit:
- Machine learning for clinical decision support in infectious diseases: a narrative review of current applicationsClinical Microbiology and Infection, 2020
- Serum HE4 and diagnosis of ovarian cancer in postmenopausal women with adnexal massesAmerican Journal of Obstetrics and Gynecology, 2020
- Genetic Algorithm2018
- An Introduction to Outlier Analysis2016
- Development of a multi-marker model combining HE4, CA125, progesterone, and estradiol for distinguishing benign from malignant pelvic masses in postmenopausal womenTumor Biology, 2015
- Diagnostic accuracy of serum HE4, CA125 and ROMA in patients with ovarian cancer: a meta-analysisTumor Biology, 2014
- Role of HE4, CA72.4, and CA125 in monitoring ovarian cancerTumor Biology, 2012
- Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic massAmerican Journal of Obstetrics and Gynecology, 2010
- 90346536 A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancerMaturitas, 1991
- Macroscopic characterization of ovarian tumors and the relation to the histological diagnosis: Criteria to be used for ultrasound evaluationGynecologic Oncology, 1989